Cover Image

Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial

BackgroundBeinaglutide, whose active ingredient is rhGLP-1, has been widely used as a pharmacological therapy for T2DM. We explored the safety and pharmacokinetics of beinaglutide in Chinese overweight/obese volunteers to lay a foundation for clinical applications of beinaglutide as an anti-obesity...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pingping Lin (Author), Chengqian Li (Author), Yanping Liu (Author), Feifei Sun (Author), Tsung-Han Hsieh (Author), Lin Zhang (Author), Yaping Ma (Author), Xiaomeng Gao (Author), Qing Yu (Author), Yu Cao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tolerability, safety, and pharmacokinetics of a single intravenous administration of a novel recombinant humanized anti-interleukin-6 receptor monoclonal antibody in healthy Chinese volunteers
by: Xin Jiang, et al.
Published: (2024)

Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects
by: Feifei Sun, et al.
Published: (2023)

Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection
by: Jiangjie Lu, et al.
Published: (2020)

The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study
by: Kuo Hsin-Chih, et al.
Published: (2009)

Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2020)

Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
by: Karen Schneck, et al.
Published: (2024)

A Randomized Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Erwinia Asparaginase (JZP‐458) in Healthy Adult Volunteers
by: Tong Lin, et al.
Published: (2021)

Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects
by: Xin Li, et al.
Published: (2023)

A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects
by: Yubin Liu, et al.
Published: (2021)

Effect of C-terminus Conjugation via Different Conjugation Chemistries on In Vivo Activity of Albumin-Conjugated Recombinant GLP-1
by: Junyong Park, et al.
Published: (2021)

Injections for weight loss: what's new in GLP-1 RAs for obesity treatment - review
by: Małgorzata Maria Zając, et al.
Published: (2024)

Compatibility of rubber stoppers for recombinant antitumor-antivirus protein injection by gas chromatography-mass spectrometry
by: Zhaorui Meng, et al.
Published: (2019)

Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity
by: Martin Haljeta Friedrichsen, et al.
Published: (2023)

Beinaglutide showed significant weight‐loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real‐world setting: a 3‐month, multicentre, observational, retrospective, open‐label study
by: Y. L. Zhang, et al.
Published: (2019)

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
by: Marie A. Printz, BA, et al.
Published: (2020)

A phase 1 study of dimdazenil to evaluate the pharmacokinetics, food effect and safety in Chinese healthy subjects
by: Fei Wang, et al.
Published: (2023)

Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparaginase (JZP458) in patients with acute lymphoblastic leukemia
by: Tong Lin, et al.
Published: (2023)

The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice
by: Mireia Montaner, et al.
Published: (2023)

Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women
by: Lammerich A, et al.
Published: (2015)

Toxicology and Pharmacokinetics Study of Intradiscal Injection of Simvastatin in Rabbits
by: Xiaodong Huang, et al.
Published: (2021)

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
by: Li Yang, et al.
Published: (2021)

A population pharmacokinetic and pharmacokinetic‐pharmacodynamic analysis of vupanorsen from phase I and phase II studies
by: Jae Eun Ahn, et al.
Published: (2023)

GLP-1 Receptor: A New Target for Sepsis
by: Fuxun Yang, et al.
Published: (2021)

Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops
by: Pei-Hsuan Lin, et al.
Published: (2016)

A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin
by: Goldwater R, et al.
Published: (2016)

Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects
by: Hyounggyoon Yoo, et al.
Published: (2022)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial
by: Yu-zhou Gui, et al.
Published: (2024)

INITIATING PATIENTS ON GLP-1/COMBINED GLP-1 AND GIP AGONISTS: A QUALITY IMPROVEMENT PROJECT
by: Shreya Srivastava, MD, MPH
Published: (2024)

The Oral Delivery System of Modified GLP-1 by Probiotics for T2DM
by: Qing Wang, et al.
Published: (2023)

Corrigendum to "Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity" [Mol Metab 78 (2023) 101801]
by: Martin Haljeta Friedrichsen, et al.
Published: (2024)

Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial
by: Deepa Joshi, et al.
Published: (2021)

GLP-1 analogs in the treatment of obesity
by: Aleksandra Metelska, et al.
Published: (2022)

GLP-1 agonists in treatment of obesity
by: Władysław Orłowski, et al.
Published: (2023)

Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
by: Hou L, et al.
Published: (2015)

Endometrial L-selectin ligand is downregulated in the mid-secretory phase during the menstrual cycle in women with adenomyosis
by: Tsung-Hsuan Lai, et al.
Published: (2018)

Sarcopenia‐related changes in serum GLP‐1 level affect myogenic differentiation
by: Hsien‐Hao Huang, et al.
Published: (2024)

Pharmacokinetics of gene recombined angiogenesis inhibitor Kringle 5 in vivo using 131I specific markers and SPECT/CT
by: Ge Yan, et al.
Published: (2016)

Neuroprotective Role of GLP-1 Analog for Retinal Ganglion Cells via PINK1/Parkin-Mediated Mitophagy in Diabetic Retinopathy
by: Huan-ran Zhou, et al.
Published: (2021)

The use of luteal-phase ovarian stimulation for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment
by: Li-Te Lin
Published: (2016)

Dermal Injection of Recombinant Filaggrin-2 Ameliorates UVB-Induced Epidermal Barrier Dysfunction and Photoaging
by: Lu Li, et al.
Published: (2024)